PL2813225T3 - Sposób leczenia zatrucia związkami fosforoorganicznymi - Google Patents
Sposób leczenia zatrucia związkami fosforoorganicznymiInfo
- Publication number
- PL2813225T3 PL2813225T3 PL14002959T PL14002959T PL2813225T3 PL 2813225 T3 PL2813225 T3 PL 2813225T3 PL 14002959 T PL14002959 T PL 14002959T PL 14002959 T PL14002959 T PL 14002959T PL 2813225 T3 PL2813225 T3 PL 2813225T3
- Authority
- PL
- Poland
- Prior art keywords
- treating
- organophosphorous poisoning
- poisoning
- treating organophosphorous
- organophosphorous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61312104P | 2004-09-24 | 2004-09-24 | |
EP05812994.1A EP1791904B1 (en) | 2004-09-24 | 2005-09-23 | Method of treating organophosphorous poisoning |
EP14002959.6A EP2813225B1 (en) | 2004-09-24 | 2005-09-23 | Method of treating organophosphorous poisoning |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2813225T3 true PL2813225T3 (pl) | 2018-11-30 |
Family
ID=36119406
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL14002959T PL2813225T3 (pl) | 2004-09-24 | 2005-09-23 | Sposób leczenia zatrucia związkami fosforoorganicznymi |
PL05812994T PL1791904T3 (pl) | 2004-09-24 | 2005-09-23 | Sposób leczenia zatrucia związkami fosforoorganicznymi |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05812994T PL1791904T3 (pl) | 2004-09-24 | 2005-09-23 | Sposób leczenia zatrucia związkami fosforoorganicznymi |
Country Status (10)
Country | Link |
---|---|
US (2) | US7888346B2 (pl) |
EP (2) | EP2813225B1 (pl) |
JP (2) | JP5710092B2 (pl) |
CN (1) | CN101044200A (pl) |
AU (1) | AU2005289808B2 (pl) |
CA (1) | CA2583439C (pl) |
ES (2) | ES2519690T3 (pl) |
IL (2) | IL182048A0 (pl) |
PL (2) | PL2813225T3 (pl) |
WO (1) | WO2006036686A2 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9132135B2 (en) * | 2004-09-24 | 2015-09-15 | University Of Maryland, Baltimore | Method of treating organophosphorous poisoning |
WO2008022365A2 (de) * | 2006-08-24 | 2008-02-28 | Sanochemia Ltd. | Mittel zum beeinflussen der wirkungen von organophosphorverbindungen und verwendung von galanthamin, dessen derivaten und analoga zum herstellen solcher mittel |
BR102013004109A2 (pt) * | 2012-09-19 | 2015-06-23 | Univ Georgetown | Lipossomas direcionados |
US20140120157A1 (en) | 2012-09-19 | 2014-05-01 | Georgetown University | Targeted liposomes |
CN103041368B (zh) * | 2013-01-18 | 2014-04-02 | 新乡医学院 | 藻蓝蛋白在制备防治有机磷农药所致胚胎毒性的药物中的应用 |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4292308A (en) * | 1979-08-21 | 1981-09-29 | Biotherapeutics, Inc. | Treatment of animals exposed to or subject to exposure to organophosphate animal poisonous nerve agents |
US4550113A (en) | 1982-08-19 | 1985-10-29 | Nauchno-Issledovatelsky Institut Po Biologicheskikm Ispytaniyam Khimicheskikh Soedineny | 9-Amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta(b)quinoline monohydrate hydrochloride as stimulant of neuro-muscular transmission of smooth muscles |
RU2057531C1 (ru) | 1986-07-01 | 1996-04-10 | Всероссийский научный центр по безопасности биологически активных веществ | Средство для стимуляции обучения и памяти |
US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
US5480651A (en) | 1992-03-16 | 1996-01-02 | Regents Of The University Of California | Composition and method for treating nicotine craving in smoking cessation |
DE4342174C1 (de) | 1993-12-10 | 1995-05-11 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung |
DE4342173A1 (de) | 1993-12-10 | 1995-06-14 | Lohmann Therapie Syst Lts | Pharmazeutische Formulierung zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer |
GB9606736D0 (en) | 1996-02-19 | 1996-06-05 | Shire International Licensing | Therapeutic method |
US6576636B2 (en) | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
TW506836B (en) * | 1996-06-14 | 2002-10-21 | Janssen Pharmaceutica Nv | Fast-dissolving galanthamine hydrobromide tablet |
US6331289B1 (en) | 1996-10-28 | 2001-12-18 | Nycomed Imaging As | Targeted diagnostic/therapeutic agents having more than one different vectors |
US6264917B1 (en) | 1996-10-28 | 2001-07-24 | Nycomed Imaging As | Targeted ultrasound contrast agents |
US6261537B1 (en) | 1996-10-28 | 2001-07-17 | Nycomed Imaging As | Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors |
AU9496798A (en) | 1997-09-19 | 1999-04-05 | Shire Laboratories, Inc. | Solid solution beadlet |
US20030077227A1 (en) | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
UA66370C2 (en) | 1997-12-16 | 2004-05-17 | Lilly Co Eli | Arylpiperazines having activity to setotonin 1 receptors |
US6211230B1 (en) * | 1999-09-27 | 2001-04-03 | The United States Of America As Represented By The Secretary Of The Army | Method of reducing brain damage resulting from seizures |
TW558554B (en) | 1999-10-29 | 2003-10-21 | Takeda Chemical Industries Ltd | Crystals of oxyiminoalkanoic acid derivative |
US6617361B2 (en) | 1999-11-05 | 2003-09-09 | Be Able, Llc | Behavior chemotherapy |
EP2311463A1 (en) | 1999-12-10 | 2011-04-20 | Bonnie M. Davis | Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
JP2001261652A (ja) | 2000-03-21 | 2001-09-26 | Suntory Ltd | 二置換イミノヘテロサイクリック化合物 |
DK1282607T3 (en) | 2000-05-08 | 2016-02-01 | Janssen Pharmaceutica Nv | Prodrugs of HIV replication inhibiting pyrimidines |
US6610713B2 (en) | 2000-05-23 | 2003-08-26 | North Shore - Long Island Jewish Research Institute | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
US6756385B2 (en) | 2000-07-31 | 2004-06-29 | Pfizer Inc. | Imidazole derivatives |
PE20020394A1 (es) | 2000-08-18 | 2002-06-21 | Agouron Pharma | Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2 |
IT1317908B1 (it) | 2000-09-15 | 2003-07-15 | S I S S A Scuola Internaz Supe | Muteine del frammento peptidico cgrp 1-7 e loro uso come potenziatoridei recettori nicotinici neuronali. |
US6589504B1 (en) | 2000-09-22 | 2003-07-08 | Pharmacia & Upjohn Company | Compounds and methods for diagnosing and treating amyloid-related conditions |
US7022725B2 (en) | 2000-11-17 | 2006-04-04 | Takeda Pharmaceutical Company Limited | Isoxazole derivatives |
JP4012068B2 (ja) | 2000-12-22 | 2007-11-21 | シェーリング コーポレイション | ムスカリンアンタゴニスト |
PL364221A1 (pl) | 2001-02-02 | 2004-12-13 | Takeda Chemical Industries, Ltd. | Skondensowane związki heterocykliczne |
AU2002253929A1 (en) | 2001-02-08 | 2002-09-24 | Schering Corporation | Use of dual h3/m2 antagonists with a bipiperidinic structure in the treatment of cognition deficit disorders |
EP1256578B1 (en) | 2001-05-11 | 2006-01-11 | Pfizer Products Inc. | Thiazole derivatives and their use as cdk inhibitors |
KR100432283B1 (ko) | 2001-10-27 | 2004-05-22 | 한국과학기술연구원 | 무스카린성 아세틸콜린 수용체에 작용하는테트라하이드로피리딘 유도체 |
KR100437972B1 (ko) | 2001-10-27 | 2004-07-02 | 한국과학기술연구원 | 피롤리디논 유도체, 이의 제조 방법 및 이를 포함하는제약 조성물 |
CN100488982C (zh) | 2001-11-02 | 2009-05-20 | 迪尔基因国际有限公司 | 与β-淀粉样蛋白结合并引起蛋白质构象转变的单克隆抗体的制备方法 |
GB0202900D0 (en) | 2002-02-07 | 2002-03-27 | Laxdale Ltd | Novel formulations of drugs |
US7015345B2 (en) | 2002-02-21 | 2006-03-21 | Asahi Kasei Pharma Corporation | Propionic acid derivatives |
WO2003092606A2 (en) | 2002-05-01 | 2003-11-13 | Eisai Co., Ltd. | Cholinesterase inhibitors to prevent injuries caused by chemicals |
CN1389462A (zh) | 2002-07-12 | 2003-01-08 | 复旦大学 | 大叶蒟素及其同系物,和在制备药物组合物中的应用 |
US7045527B2 (en) | 2002-09-24 | 2006-05-16 | Amgen Inc. | Piperidine derivatives |
US20040067934A1 (en) | 2002-10-03 | 2004-04-08 | Parys Wim Louis Julien | Use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease |
JP4288263B2 (ja) | 2002-10-25 | 2009-07-01 | コレジウム ファーマシューティカル, インク. | p−ヒドロキシ−ミルナシプランの立体異性体およびその使用方法 |
US20050013869A1 (en) * | 2003-07-18 | 2005-01-20 | Chaw Cheng Shu | Sustained release formulation for carbamates and a method therefor |
-
2005
- 2005-09-23 CA CA2583439A patent/CA2583439C/en not_active Expired - Fee Related
- 2005-09-23 ES ES05812994.1T patent/ES2519690T3/es active Active
- 2005-09-23 AU AU2005289808A patent/AU2005289808B2/en not_active Ceased
- 2005-09-23 CN CNA2005800360631A patent/CN101044200A/zh active Pending
- 2005-09-23 WO PCT/US2005/033789 patent/WO2006036686A2/en active Application Filing
- 2005-09-23 PL PL14002959T patent/PL2813225T3/pl unknown
- 2005-09-23 EP EP14002959.6A patent/EP2813225B1/en active Active
- 2005-09-23 JP JP2007533601A patent/JP5710092B2/ja not_active Expired - Fee Related
- 2005-09-23 ES ES14002959.6T patent/ES2662868T3/es active Active
- 2005-09-23 PL PL05812994T patent/PL1791904T3/pl unknown
- 2005-09-23 US US11/575,945 patent/US7888346B2/en not_active Expired - Fee Related
- 2005-09-23 EP EP05812994.1A patent/EP1791904B1/en active Active
-
2007
- 2007-03-20 IL IL182048A patent/IL182048A0/en not_active IP Right Cessation
-
2011
- 2011-02-14 US US13/027,129 patent/US8703762B2/en not_active Expired - Fee Related
-
2012
- 2012-02-22 IL IL218241A patent/IL218241A/en not_active IP Right Cessation
-
2013
- 2013-04-24 JP JP2013091045A patent/JP2013173773A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2813225B1 (en) | 2017-12-13 |
US8703762B2 (en) | 2014-04-22 |
PL1791904T3 (pl) | 2015-02-27 |
AU2005289808A1 (en) | 2006-04-06 |
ES2662868T3 (es) | 2018-04-10 |
JP5710092B2 (ja) | 2015-04-30 |
JP2008514609A (ja) | 2008-05-08 |
EP2813225A1 (en) | 2014-12-17 |
EP1791904B1 (en) | 2014-08-27 |
IL218241A (en) | 2016-03-31 |
AU2005289808A2 (en) | 2008-07-31 |
US20110144093A1 (en) | 2011-06-16 |
EP1791904A2 (en) | 2007-06-06 |
CA2583439A1 (en) | 2006-04-06 |
US7888346B2 (en) | 2011-02-15 |
EP1791904A4 (en) | 2009-01-21 |
ES2519690T3 (es) | 2014-11-07 |
WO2006036686A3 (en) | 2007-02-22 |
IL182048A0 (en) | 2007-07-24 |
CA2583439C (en) | 2016-05-10 |
WO2006036686A2 (en) | 2006-04-06 |
US20080070900A1 (en) | 2008-03-20 |
CN101044200A (zh) | 2007-09-26 |
IL218241A0 (en) | 2012-04-30 |
AU2005289808B2 (en) | 2011-11-03 |
JP2013173773A (ja) | 2013-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1220612A1 (zh) | 治療炎症相關疾病的方法 | |
IL180742A0 (en) | Method of manufacture | |
EP1838714A4 (en) | METHODS OF TREATING PAIN | |
ZA200705059B (en) | Cancer treatment method | |
IL179323A0 (en) | Cancer treatment method | |
GB0422004D0 (en) | Method of deprotection | |
IL218241A0 (en) | Method of treating organophosphorous poisoning | |
IL159893A0 (en) | Method of terrain following | |
EP1809276A4 (en) | PROCESSING PROCESS | |
IL179359A0 (en) | Cancer treatment method | |
EP1781322A4 (en) | METHOD OF TREATING DIABETES | |
EP1737445A4 (en) | METHOD FOR TREATING DOWN SYNDROME | |
GB0422533D0 (en) | Non-aqueous treatment method | |
EP1856733A4 (en) | METHOD FOR LED MICRO PACKAGING AND MICRO PACKAGING | |
EP1802617A4 (en) | CANCER TREATMENT METHOD | |
GB0426196D0 (en) | Methods of treatment | |
EP1843780A4 (en) | Methods of Treatment | |
EP1688503A4 (en) | METHOD FOR THE TREATMENT OF CELLS | |
GB0400122D0 (en) | Method of quantifying binding | |
GB0408799D0 (en) | Method of treating pain | |
HU0402689D0 (en) | Method for regeneration of zeolits | |
PL366960A1 (pl) | Sposób modyfikacji bio-membran | |
GB0419826D0 (en) | Method of determination | |
GB0415170D0 (en) | Method of determination | |
HUP0401136A3 (en) | Method for post-blinding of gas-plumbing |